The FDA has accepted the application for suzetrigine, an experimental, non-opioid pain medicine. If approved, the drug will be the nation's first of a new class of pain medicine in more than 20 years. 

Advocate Health, a system with 68 hospitals across six states, recently surveyed its pharmacists to uncover areas of improvement and differences in opinion, according to the American Society of Health-System Pharmacists. 

The fully remote PharmD program at University of Colorado Skaggs School of Pharmacy and Pharmaceutical Science in Aurora has received full accreditation from the Accreditation Council for Pharmacy Education. 

Hospitals spent about 7% of annual pharmaceutical spend on infectious disease treatments, according to a Vizient report released July 30. 

Health systems spent 77% more on semaglutide, the active ingredient of Ozempic and Wegovy, between April 2023 and March 2024, compared to the prior year, according to Vizient's Pharmacy Market Outlook. 

Patients are becoming less satisfied with physical pharmacies as popularity rises for online and mail-order services, according to J.D. Power's 16th annual U.S. Pharmacy Study.

Between April 2023 and March 2024, Humira accounted for top medication spend for Vizient pharmacy program participants, according to a Vizient report published July 30. 

In the second quarter of 2024, there were 300 medications in shortage across the U.S. 

Loma Linda (Calif.) University Health is collaborating with data analytics firm Loopback Analytics to level up the health system's specialty pharmacy services.

A generic drugmaker likely will shut down if it does not receive federal assistance, The Wall Street Journal reported July 26.